{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:13:27Z","timestamp":1760116407318,"version":"build-2065373602"},"reference-count":10,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Chronic hepatitis B (CHB) affects approximately 300 million people worldwide and current therapies rarely cure it [...]<\/jats:p>","DOI":"10.3390\/v16111793","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T04:53:05Z","timestamp":1731991985000},"page":"1793","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding and Targeting HBV Transcription and Post-Transcriptional Regulation"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1987-6179","authenticated-orcid":false,"given":"Simon P.","family":"Fletcher","sequence":"first","affiliation":[{"name":"Gilead Sciences, Foster City, CA 94404, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5435-8014","authenticated-orcid":false,"given":"Rudolf K.","family":"Beran","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Foster City, CA 94404, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Niu, C., Livingston, C.M., Li, L., Beran, R.K., Daffis, S., Ramakrishnan, D., Burdette, D., Peiser, L., Salas, E., and Ramos, H. (2017). The smc5\/6 complex restricts hbv when localized to nd10 without inducing an innate immune response and is counteracted by the hbv x protein shortly after infection. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0169648"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e0032823","DOI":"10.1128\/jvi.00328-23","article-title":"Slf2 interacts with the smc5\/6 complex to direct hepatitis b virus episomal DNA to promyelocytic leukemia bodies for transcriptional repression","volume":"97","author":"Yao","year":"2023","journal-title":"J. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.molcel.2020.11.011","article-title":"The smc5\/6 core complex is a structure-specific DNA binding and compacting machine","volume":"80","author":"Serrano","year":"2020","journal-title":"Mol. Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.molcel.2020.11.012","article-title":"Purified smc5\/6 complex exhibits DNA substrate recognition and compaction","volume":"80","author":"Hormeno","year":"2020","journal-title":"Mol. Cell"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Giraud, G., El Achi, K., Zoulim, F., and Testoni, B. (2024). Co-transcriptional regulation of hbv replication: Rna quality also matters. Viruses, 16.","DOI":"10.3390\/v16040615"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Mouzannar, K., Schauer, A., and Liang, T.J. (2024). The post-transcriptional regulatory element of hepatitis b virus: From discovery to therapy. Viruses, 16.","DOI":"10.3390\/v16040528"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.30329","article-title":"Papd5\/7 are host factors that are required for hepatitis b virus rna stabilization","volume":"69","author":"Mueller","year":"2019","journal-title":"Hepatology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"eaan0241","DOI":"10.1126\/scitranslmed.aan0241","article-title":"Rnai-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis b virus DNA is a source of hbsag","volume":"9","author":"Wooddell","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4254\/wjh.v16.i3.331","article-title":"Advances in discovery of novel investigational agents for functional cure of chronic hepatitis b: A comprehensive review of phases ii and iii therapeutic agents","volume":"16","author":"Lam","year":"2024","journal-title":"World J. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1056\/NEJMoa2210027","article-title":"Efficacy and safety of bepirovirsen in chronic hepatitis b infection","volume":"387","author":"Yuen","year":"2022","journal-title":"N. Engl. J. Med."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/11\/1793\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:34:59Z","timestamp":1760114099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/11\/1793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":10,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["v16111793"],"URL":"https:\/\/doi.org\/10.3390\/v16111793","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2024,11,19]]}}}